104 related articles for article (PubMed ID: 11189505)
41. Renal function after autologous bone marrow transplantation in children: a long-term prospective study.
Frisk P; Bratteby LE; Carlson K; Lönnerholm G
Bone Marrow Transplant; 2002 Jan; 29(2):129-36. PubMed ID: 11850707
[TBL] [Abstract][Full Text] [Related]
42. Changes in thyroid function after bone marrow transplant in young patients.
Matsumoto M; Ishiguro H; Tomita Y; Inoue H; Yasuda Y; Shimizu T; Shinagawa T; Hattori K; Yabe H; Kubota C; Yabe M; Kato S; Shinohara O
Pediatr Int; 2004 Jun; 46(3):291-5. PubMed ID: 15151545
[TBL] [Abstract][Full Text] [Related]
43. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
Kanda Y; Sakamaki H; Sao H; Okamoto S; Kodera Y; Tanosaki R; Kasai M; Hiraoka A; Takahashi S; Miyawaki S; Kawase T; Morishima Y; Kato S;
Biol Blood Marrow Transplant; 2005 Nov; 11(11):881-9. PubMed ID: 16275591
[TBL] [Abstract][Full Text] [Related]
44. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
Sasaki Y; Ito K
Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287
[TBL] [Abstract][Full Text] [Related]
45. Minimal residual disease status in pre-B acute lymphoblastic leukemia patients after chemotherapy and bone marrow transplantation: assessment of the anti-leukemic effects of chemotherapy and BMT.
Kiyoi H; Naoe T; Yamauchi T; Fukatani H; Kubo K; Kojima S; Ohno R
Leuk Res; 1993 Aug; 17(8):677-84. PubMed ID: 8355512
[TBL] [Abstract][Full Text] [Related]
46. Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation.
Döbert N; Martin H; Kranert WT; Menzel C; Klein SA; Mose S; Grünwald F
Clin Nucl Med; 2003 Sep; 28(9):738-42. PubMed ID: 12972995
[TBL] [Abstract][Full Text] [Related]
47. A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
Weiss MA; Aliff TB; Tallman MS; Frankel SR; Kalaycio ME; Maslak PG; Jurcic JG; Scheinberg DA; Roma TE
Cancer; 2002 Aug; 95(3):581-7. PubMed ID: 12209751
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of clinical outcome between allogeneic peripheral blood stem cell transplantation and bone marrow transplantation].
Wang M; Han M; Feng S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):427-30. PubMed ID: 11721425
[TBL] [Abstract][Full Text] [Related]
49. Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia.
Kang HJ; Shin HY; Choi HS; Han KS; Ahn HS
Bone Marrow Transplant; 2004 Mar; 33(5):471-6. PubMed ID: 14716339
[TBL] [Abstract][Full Text] [Related]
50. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
51. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
Vicent MG; Madero L; Ortega JJ; Martinez A; Gomez P; Verdeguer A; Badell I; Muñoz A; Olive T; Maldonado MS; Bureo E; Cubells J; Diaz MA;
Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771
[TBL] [Abstract][Full Text] [Related]
52. Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.
Talano JM; Casper JT; Camitta BM; Keever-Taylor CA; Murray KJ; Eapen M; Pierce KL; Margolis DA
Bone Marrow Transplant; 2006 Jan; 37(2):135-41. PubMed ID: 16273115
[TBL] [Abstract][Full Text] [Related]
53. Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse.
Miglino M; Berisso G; Grasso R; Canepa L; Clavio M; Pierri I; Pietrasanta D; Gatto S; Varaldo R; Ballerini F; Verdiani S; Casarino L; DeStefano F; Sessarego M; Dominietto A; Raiola AM; Bregante S; di Grazia C; Gobbi M; Bacigalupo A
Bone Marrow Transplant; 2002 Nov; 30(9):579-85. PubMed ID: 12407432
[TBL] [Abstract][Full Text] [Related]
54. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
Houtenbos I; Bracho F; Davenport V; Slack R; van de Ven C; Suen Y; Killen R; Shen V; Cairo MS
Bone Marrow Transplant; 2001 Jan; 27(2):145-53. PubMed ID: 11281383
[TBL] [Abstract][Full Text] [Related]
55. [Hematopoietic stem cell transplantation with conditioning regimens containing melphalan in pediatric patients with acute lymphoblastic leukemia].
Matsuyama T; Kato K; Hanada R; Kawa K; Okamura J; Tsuchida M; Kigasawa H; Watanabe A; Hamamoto K; Kudoh T; Sano K; Ohira M;
Rinsho Ketsueki; 2002 Jul; 43(7):527-37. PubMed ID: 12229121
[TBL] [Abstract][Full Text] [Related]
56. Treatment of isolated central nervous system relapse in high-risk lymphoid malignancy with allogeneic bone marrow transplantation and extended intrathecal therapy.
Nagatoshi Y; Kawano Y; Nagayama J; Okamura J
Br J Haematol; 2004 Jun; 125(6):766-8. PubMed ID: 15180866
[TBL] [Abstract][Full Text] [Related]
57. Thyroid, parathyroid, gonadal, and pancreatic beta-cell function after bone marrow transplantation with chemotherapy-only conditioning.
Ghavamzadeh A; Larijani B; Jahani M; Khoshniat M; Bahar B; Tabatabaei O
Transplant Proc; 2003 Dec; 35(8):3101-4. PubMed ID: 14697989
[TBL] [Abstract][Full Text] [Related]
58. [Reduced intensity of BuCy conditioning regimen for transplantation in the treatment of malignant hematologic diseases].
Chen H; Lu DP; Huang XJ; Liu KY; Xu LP; Han W; Ren HY; Chen YH; Liu DH; Lu J; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):273-6. PubMed ID: 15949287
[TBL] [Abstract][Full Text] [Related]
59. Early post-BMT liver function in children with acute leukemia conditioned for allo-BMT with Busulfan-containing and with FTBI-containing preparative regimens.
Wachowiak J; Boruczkowski D; Malicki J; Chobot-Musiałkiewicz U
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S96-9. PubMed ID: 9916649
[No Abstract] [Full Text] [Related]
60. A prospective study of the effects of high-dose chemotherapy and bone marrow transplantation on sexual function in the first year after transplant.
Marks DI; Friedman SH; Delli Carpini L; Nezu CM; Nezu AM
Bone Marrow Transplant; 1997 Apr; 19(8):819-22. PubMed ID: 9134175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
